Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions with Circumsporozoite Protein Antigens

about

Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions with Circumsporozoite Protein Antigens

Item

http://www.wikidata.org/entity/Q56342409

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 13 July 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Qualified Biolayer Interferome ...... cumsporozoite Protein Antigens

@en

Qualified Biolayer Interferome ...... cumsporozoite Protein Antigens

@nl

type

Item

label

Qualified Biolayer Interferome ...... cumsporozoite Protein Antigens

@en

Qualified Biolayer Interferome ...... cumsporozoite Protein Antigens

@nl

prefLabel

Qualified Biolayer Interferome ...... cumsporozoite Protein Antigens

@en

Qualified Biolayer Interferome ...... cumsporozoite Protein Antigens

@nl

P1476

Qualified Biolayer Interferome ...... cumsporozoite Protein Antigens

@en

P2093

Daniel A Ozaki

http://www.w3.org/2001/XMLSchema#string

Marcella Sarzotti-Kelsoe

http://www.w3.org/2001/XMLSchema#string

Matthew Reichartz

http://www.w3.org/2001/XMLSchema#string

S Munir Alam

http://www.w3.org/2001/XMLSchema#string

Sheetij Dutta

http://www.w3.org/2001/XMLSchema#string

Ulrike Wille-Reece

http://www.w3.org/2001/XMLSchema#string

Wes Rountree

http://www.w3.org/2001/XMLSchema#string

P2860

Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection

Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

The RTS,S malaria vaccine

Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data.

Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen.

The journey of the malaria sporozoite through its hosts: two parasite proteins lead the way.

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

P304

1315-1326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1800323

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

201

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30006374

http://www.w3.org/2001/XMLSchema#string

P921

immunology

P932

6077849

http://www.w3.org/2001/XMLSchema#string